Join us at eCheminfo Euro

eChemInfo workshop

Final Announcement for the eChemInfo Training and Innovation Course in Drug Design 2017 in Milano

This is a final reminder that the Training and Innovation Course in Drug Design will take place at the Department of Pharmaceutical Sciences, University of Milano from Mon, 17 Jul. to Fri, 21 Jul. 2017.

The final program is available at http://www.echeminfo.com/events/drug-design-euro-2017

We will have three exiting key notes:

  • Malaria Drug Discovery Methods, Donatella Taramelli, University of Milan
  • Aspects of Industrial Drug Design, Anna Maria Capelli, Chiesi
  • Design of Cyclopeptidic Drugs, Laura Belvisi / Monica Civera, University of Milan

We are also very happy to be able this year to strongly integrate experimental techniques into the workshop. Stefan Jehle from Bruker BioSpin AG, the leading company in biomolecular NMR spectroscopy, will give a session on “NMR-driven Fragment Based Drug Design”. And we have Anthony Bradley from the Diamond Light Source's XChem project, which provides services for complex structure determination using medium- to high-throughput X-ray. He will give a presentation together with Tim Dudgeon (Informatics Matters) on “Moving from Individual Tools to Complete Workflows”.

And just to remind you on our special setup of the workshop: Use the “bring your own problems” option to directly apply your newly acquired knowledge to your own research, profit from specific advice by the experts and other participants and contribute to innovative approaches for all case studies. You can also present a poster of your work to give the other attendees an overview of your work and foster discussions within the groups.

We would highly appreciate if you could showcase the workshop poster (http://www.echeminfo.com/Milano2017_Poster.pdf) on your notice boards.

Register now at https://goo.gl/au4QBW

 

Dr Thomas Exner is a Chief Scientific Officer (CSO) at Douglas Connect

 

About Edelweiss Connect

Edelweiss Connect has developed computer software that helps combine data from many different sources and formats into a useable form for evaluation and re-use. In addition, we have developed other software programs that can use the collected data and data from in vitro tests to predict the safety of chemical compounds in the human body.

Tags

Latest Tweets

Edelweiss Connect (4 days ago)
@Vertexlabs_ "We specialize in AI, Machine Learning, and Deep Learning - all very data-centric. What we bring to th… https://t.co/TY4w850dbx
Edelweiss Connect (4 days ago)
We are proud to announce #SaferWorldbyDesign founding partners - Edelweiss Connect, Biopredic International, Eurosa… https://t.co/IUkD8FpUqb
Edelweiss Connect (4 days ago)
RT @LucianFarcal: How do you store and share the protocols on #nanomaterials #physicochemical #characterisation? Read about the newest rele…
Edelweiss Connect (5 days ago)
Making AI available to companies, large and small - CEO Tom Bell explains why @Vertexlabs_ is a founding member of… https://t.co/oj7y7jNqq0
Edelweiss Connect (2 weeks ago)
#SaferWorldbyDesign is a new solution-oriented, safety assessment framework to support the design of intelligent, s… https://t.co/Rv6BsS7HHb

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 633 29 78
  • Email: info@edelweissconnect.com

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA
  • Phone: +1 252 654 9003
  • Email: info@edelweissconnect.com